首页 > 市场调查报告书 > 製药

妇科治疗

市场调查报告书

商品编码

1618439

避孕产品市场规模：按产品、按年龄层、按性别、按分销管道、按地区、范围和预测

Contraceptives Market Size By Product (Drugs, Devices), By Age Group (Age 15-24, Age 25-34, Age 35-44, Above 44), By Gender (Male, Female), By Distribution Channel (Institutional Sales, Retail Sales, Online Sales), By Geographic Scope And Forecast

出版日期: 2024年09月09日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格

简介目录

避孕用品市场规模及预测

2023年避孕产品市场规模为200.7亿美元，预估2024年至2031年复合年增长率为5.81%，2031年达315.4亿美元。避孕产品，俗称避孕方法，是用来预防怀孕的各种药物或行为介入。避孕产品的主要目的是抑製或控制生殖过程，使个人或夫妇能够根据自己的意愿规划和安排怀孕。这些干预措施可以采取多种形式，包括口服药或注射剂等荷尔蒙避孕药、子宫内避孕器 (IUD)、保险套等屏障方法以及生育意识实践。

除了防止意外怀孕外，避孕产品还可以帮助您控制生育时间和间隔，从而帮助计划生育。

此外，避孕药也可用于治疗某些健康问题，例如调节月经和治疗多囊性卵巢症候群（PCOS）。

避孕产品市场动态

影响避孕产品市场的主要市场动态是：

主要市场推动因素

计划生育意识不断增强：

近年来，社会对生殖健康（性健康和生殖健康）的认识发生了显着变化，并强调对计划生育做出明智的决定。教育活动、医疗保健举措以及透过众多媒体管道大规模传播讯息正在推动人们的认识不断提高。因此，推动避孕产品市场的关键因素之一是对计划生育意识的增强。

政府的避孕方法：

认识到控制人口成长的社会和经济效益，一些政府推出了全面的计划生育计划。这些计划往往包括补贴或免费分发避孕药、教育活动以及改善医疗保健基础设施等活动。因此，政府避孕措施是避孕产品市场的主要驱动力。

扩大男性对避孕药具的接受度：

对避孕套和脉管系统等男性避孕用品的接受表明了向共同计划生育的积极文化转变。男性积极参与避孕决策不仅为夫妇提供了更多选择，也培养了对生殖决策的平等意识。这种观点的变化透过增加使用者数量和扩大所提供的避孕方法的范围，对整体市场的成长是正面的。

主要课题

副作用：

某些避孕方法，尤其是荷尔蒙方法，如口服避孕药和注射剂，可能会导致噁心、体重增加和情绪问题。因此，儘管避孕有多种好处，但市场成长的主要障碍之一是对其使用相关的潜在副作用和健康影响的担忧。

文化/宗教对立：

一些文化和宗教对生殖健康和计划生育持保守观点，并认为避孕违反道德或宗教戒律。这种反对的形式可能是限制获取资讯、限制取得避孕药具或使用社会压力。因此，文化和宗教态度仍然是某些国家和群体普遍接受避孕的重要障碍。

与避孕相关的社会耻辱：

误解、文化禁忌和社会判断都可能导致在获得或使用避孕药具时感到羞耻和尴尬。这种耻辱阻碍了人们自由讨论和使用避孕方法，并阻碍了计划生育的成功。

主要趋势：

长效可逆避孕产品 (LARC) 的需求增加：

LARC，包括子宫内避孕器 (IUD) 和植入式避孕器，透过单次介入即可提供长期避孕效果，使其成为日常或常规避孕方法的便捷有效替代方案。LARC 因其高有效率、长期稳定性和低使用者依赖性而具有吸引力，使其成为那些寻求可靠、低维护避孕方法的人的理想选择。这一趋势正在增加避孕市场对 LARC 的需求。

男性避孕方法的增加：

男性避孕方法，包括正在开发的保险套、脉管系统和荷尔蒙避孕产品，提供了更广泛的选择。这种趋势不仅促进了生育决策的平等参与，而且为夫妇提供了更广泛的选择，并根据个人喜好和需求量身定制计划生育策略。

避孕用品市场区域分析

避孕产品市场更详细的区域分析

北美：

根据验证市场研究，预计北美在预测期内将主导避孕产品市场。该地区交通便利且完善的监管框架支持多种避孕产品的供应。这个成熟的市场为客户提供了多种选择，体现了该地区对生殖健康和计划生育的奉献精神。

高认知度和广泛可用性也是北美的驱动力。此外，该地区的现代医疗保健系统确保了避孕药具的广泛使用，各行各业的人们都可以轻鬆获得避孕药具。

此外，该地区在生殖健康解决方案中采用和融入最新技术方面处于领先地位。在北美，智慧型手机生育追踪应用程式、智慧避孕设备和荷尔蒙避孕方法的进步等创新已被广泛接受，促进了动态和进步的市场环境。

欧洲：

欧洲避孕产品市场的特征是传统方法和新方法的平衡结合。该地区对性健康和生殖健康的重视体现在随时可用的医疗服务和公众宣传工作上。欧洲广泛的文化背景创造了多元化的市场，支持广泛的品味和计划生育选择。

提高大众对性传染感染和其他健康问题的认识是推动欧洲采用避孕药具的主要因素之一。人们越来越意识到生殖健康与整体健康之间的联繫，并积极寻找和使用可靠的避孕药具。这种注重健康的方法促进了对各种避孕选择的持续需求，包括荷尔蒙和屏障方法。

此外，欧洲推迟生育的趋势日益明显，越来越多的人选择在晚年建立家庭。随着人们寻求有效的方法来计划和间隔怀孕，社会规范的这些变化促使避孕需求的增加。欧洲市场的因应措施是为面临母亲发育迟缓这一复杂问题的人们提供各种解决方案。

亚太地区：

由于人口成长、意识提高和医疗基础设施改善，亚太地区已成为一个充满活力且快速扩张的避孕产品市场。该地区不同的文化背景影响着各种避孕方法的采用，为市场竞争者创造了机会和课题。

印度和中国等国家的出生率很高，人们对计划生育的兴趣增加，对有效避孕的需求也增加。政府措施和宣传活动积极促进避孕措施的使用，将其作为控制该地区人口增长的负责任方式。

此外，教育活动对于提高亚太地区的避孕意识也很重要。大众对避孕产品的认识和接受度不断提高，是政府、非政府组织和卫生保健专业人员加大努力教育大众瞭解该地区计划生育选择的结果。

Contraceptives Market size was valued at USD 20.07 Billion in 2023 and is projected to reach USD 31.54 Billion by 2031, growing at a CAGR of 5.81% from 2024 to 2031. Contraceptives, commonly known as birth control methods, are a variety of pharmacological or behavioral interventions used to prevent pregnancy. Contraceptives are primarily designed to inhibit or control the reproductive process, allowing individuals or couples to plan and schedule their pregnancies according to their desires. These interventions can include several forms, including hormonal contraceptives like oral tablets and injectables, intrauterine devices (IUDs), barrier methods like condoms, and fertility awareness practices.

Contraceptives are useful for more than just preventing unwanted pregnancies; they also aid in family planning by allowing individuals to control the timing and spacing of childbirth.

Moreover, contraceptives can be used to treat certain health issues, such as regulating menstrual periods and treating polycystic ovarian syndrome (PCOS).

Contraceptives Market Dynamics

The key market dynamics that are shaping the Contraceptives Market include:

Key Market Drivers

Increasing Awareness of Family Planning:

In recent years, there has been a significant shift in social attitudes regarding reproductive health, with an increased emphasis on making educated family planning decisions. The increase in awareness is being driven by educational campaigns, healthcare initiatives, and the mass diffusion of information via numerous media platforms. As a result, one of the key drivers fueling the contraceptive market is growing awareness of family planning.

Government Initiatives for Birth Control:

Recognizing the societal and economic benefits of controlled population increase, several governments are introducing comprehensive family planning programs. These programs tend to involve activities such as subsidized or free contraception distribution, educational campaigns, and healthcare infrastructure improvement. Thus, government birth control measures are a big driver of the Contraceptives Market.

Growing Acceptance of Contraceptives among Men:

The acceptability of male contraceptives such as condoms and vasectomy demonstrates a good cultural change toward shared family planning. Men who actively participate in contraceptive decisions not only provide couples with more options but also develop a sense of equality in reproductive decision-making. This changing perspective adds to overall market growth by increasing the number of users and broadening the contraceptive methods offered.

Key Challenges:

Side Effects:

Certain contraceptive methods, particularly hormonal ones such as oral contraceptives or injectables, might cause nausea, weight gain, or mood problems. As a result, despite the various benefits of contraception, one key barrier to market growth is anxiety about potential side effects and health consequences connected with their use.

Cultural and Religious Opposition:

Some cultures and religions hold conservative views on reproductive health and family planning, seeing contraception as contradictory to moral or religious precepts. This opposition takes the shape of limited information access, restricted contraceptive availability, or even societal pressure against its usage. Thus, cultural and religious attitudes continue to be important barriers to universal acceptance of contraception in certain countries and populations.

Social Stigma Associated with Contraceptives:

Misconceptions, cultural taboos, and societal judgments all lead to feelings of shame or embarrassment when obtaining or using contraception. This stigma discourages people from freely discussing or using contraceptive choices, which hinders successful family planning.

Key Trends:

Increasing Demand for Long-Acting Reversible Contraceptives (LARCs):

LARCs, which include intrauterine devices (IUDs) and contraceptive implants, provide long-term protection with a single intervention, making them a convenient and effective alternative to daily or regular contraception techniques. LARCs are appealing because of their high efficacy rates, long-term stability, and minimal user-dependent factors, making them ideal for people looking for dependable and low-maintenance birth control options. This trend results rise in demand for LARCs in the contraceptive market.

Rise in Male Contraception Methods:

Male contraceptives, including condoms, vasectomy, and developing hormonal contraceptives, provide a broader choice of possibilities. This trend not only promotes equal participation in reproductive decision-making but also offers couples a wider range of options, personalizing family planning tactics to their specific preferences and needs.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Contraceptives Market Regional Analysis

Here is a more detailed regional analysis of the Contraceptives Market:

North America:

According to Verified Market Research, North America is estimated to dominate the Contraceptives Market during the forecast period. The high level of accessibility and a well-established regulatory framework in the region supports the availability of a diverse range of contraceptive products. This mature market provides customers with a variety of options, demonstrating the region's dedication to reproductive health and family planning.

The prevalence of high awareness and accessibility is another driving force in North America. Moreover, the region's modern healthcare system guarantees widespread access to contraceptive products, making it simple for people from all walks of life to obtain them.

Furthermore, the region is at the forefront of adopting and incorporating modern technology into reproductive health solutions. In North America, innovations like as smartphone fertility tracking apps, smart contraceptive devices, and advances in hormonal contraceptive methods are widely accepted, contributing to a dynamic and progressive market environment.

Europe:

Europe has a well-established Contraceptives Market that is characterized by a balanced mix of conventional and new methods. The region's emphasis on sexual and reproductive health is apparent in readily available healthcare services and popular awareness initiatives. Europe's broad cultural backdrop contributes to a diverse market, supporting a wide range of preferences and family planning options.

The population's growing awareness about sexually transmitted diseases and other health issues is one of the main factors bolstering the application of contraceptives in Europe. Individuals are becoming more aware of the link between reproductive health and general well-being, prompting them to actively seek out and use dependable contraceptives. This health-conscious approach contributes to a consistent demand for a variety of contraception choices, including hormonal and barrier methods.

Furthermore, Europe is witnessing an increasing trend of delayed motherhood, with people choosing to start families later in life. This shift in societal standards contributes to a rise in demand for contraception, as people seek efficient ways to plan and space their pregnancies. The European market responds by providing a variety of solutions for individuals navigating the complications of delayed motherhood.

Asia Pacific:

Asia Pacific emerges as a vibrant and fast-expanding Contraceptives Market, driven by a mix of population growth, increased awareness, and improved healthcare infrastructure. The region's diverse cultural landscape influences the adoption of various contraceptive methods, giving both possibilities and problems for market competitors.

High birth rates in countries like India and China have heightened the focus on family planning, driving up demand for effective contraception. Government initiatives and awareness campaigns actively promote the use of contraception as a responsible way to regulate population increase in this region.

Furthermore, educational campaigns are important in raising awareness about contraception in Asia Pacific. Growing public awareness and acceptance of contraceptives is a result of increased efforts by governments, non-governmental organizations, and healthcare practitioners to educate the public about family planning alternatives in this region.

Contraceptives Market: Segmentation Analysis

The Contraceptives Market is segmented based on Product, Age Group, Gender, Distribution Channel, And Geography.

Contraceptives Market, By Product

Drugs
Oral Contraceptive Pills
Injectable Contraceptives
Topical Contraceptives
Devices
Condoms
Diaphragms
Contraceptive Sponges
Vaginal Rings
Cervical Cap
Subdermal Implants
Intra-uterine Devices

Based on Product, the market is segmented into Drugs and Devices. The hot-melt segment is estimated to dominate the Contraceptives Market. The devices segment dominates the Contraceptives Market. Devices, such as intrauterine devices (IUDs) and contraceptive implants, have gained popularity due to their significant benefits over traditional techniques. These devices provide a long-term and hassle-free alternative to birth control, meeting the modern lifestyle needs for simplicity and dependability. The effectiveness of devices in preventing unplanned pregnancies, combined with their low maintenance requirements, has contributed to their growing popularity among users wanting longer periods of protection without daily involvement. Moreover, advances in device technology, such as the creation of hormonal-releasing IUDs, improve their efficacy and customer satisfaction.

Contraceptives Market, By Age Group

Age 15-24
Age 25-34
Age 35-44
Above 44

Based on Age Group, the market is segmented into Age 15-24, Age 25-34, Age 35-44, and above 44. The 25-34 age group is estimated to dominate the Contraceptives Market during the forecast period. This age group reflects a life stage marked by higher education, career advancement, and the building of stable partnerships. Individuals in this age group are frequently more active in family planning, looking for dependable contraceptive methods that correspond with their life objectives and aspirations. The desire for control over reproductive choices, along with a greater understanding of the significance of responsible family planning, promotes the demand for contraception among people aged 25 to 34.

Contraceptives Market, By Gender

Male
Female

Based on Gender, the market is segmented into Male and Female. The female segment is estimated to dominate the Contraceptives Market during the forecast period. Women have traditionally been the key decision-makers and users of contraceptive techniques, which include a wide range of alternatives from hormonal contraceptives such as oral tablets and injectables to intrauterine devices (IUDs) and barrier methods like condoms. The prevalence of female-centric contraceptive techniques is consistent with biological and societal considerations, as women bear the physical cost of pregnancy and childbirth. Moreover, the evolution of societal norms, in which women are increasingly taking an active role in reproductive health decisions, strengthens their position in the contraceptive industry.

Based on Distribution Channel, the market is segmented into Institutional Sales, Retail Sales, and Online Sales. The retail sales segment is estimated to dominate the market over the forecast period. Retail sales channels, such as pharmacies, supermarkets, and convenience stores, account for a significant share due to their extensive accessibility and convenience for people looking for contraceptives. These stores offer a discrete and easily accessible setting for people to buy contraception, encouraging a sense of privacy and comfort. In addition, having a varied range of contraceptive options on retail shelves allows consumers to make informed decisions based on their tastes and individual needs. The retail distribution channel not only meets immediate consumer needs, but also serves as an important educational platform, with knowledgeable employees providing advice and information.

Key Players

The "Contraceptives Market" study report will provide valuable insight emphasizing the global market. The major players in the market are
Pfizer, Bayer AG, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Novartis AG, Merck & Co. Inc., Shionogi & Co. Ltd., Hisamitsu Pharmaceutical Co. Inc., HIKMA Pharmaceuticals PLC, Lupin Limited, Mankind Pharma Ltd., Glenmark Pharmaceuticals Ltd., Cipla Limited, Abbott Laboratories, Organon & Co., Besins Healthcare Pvt. Ltd., Famy Care Ltd., and DKT International.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

In January 2024, Evotec, a medicinal discovery and development business, announced a collaboration with Bayer to create a non-hormonal oral male contraception. This announcement marks a significant advancement in the ongoing hunt for novel and effective male contraceptive methods.
In January 2024, Teva received FDA approval for Phexxi(R), a non-hormonal vaginal contraception gel. This new method gives women another way to avoid conception without taking hormones.
In December 2023, Organon announced positive Phase 3 clinical trial findings for AM001, a new long-acting injectable contraception. This new approach could provide women with an easy and efficient form of contraception for up to six months.
In November 2023, The Bill & Melinda Gates Foundation announced a $8.3 million grant to research a three-month-long-acting contraceptive patch. This new alternative may be especially valuable in areas with limited access to healthcare.

1. INTRODUCTION OF GLOBAL CONTRACEPTIVES MARKET

1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources

4. GLOBAL CONTRACEPTIVES MARKET OUTLOOK

4.1. Overview
4.2. Market Dynamics
- 4.2.1. Drivers
- 4.2.2. Restraints
- 4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis

5. GLOBAL CONTRACEPTIVES MARKET, BY PRODUCT

5.1. Overview
5.2. Drugs
- 5.2.1. Oral Contraceptive Pills
- 5.2.2. Injectable Contraceptives
- 5.2.3. Topical Contraceptives
5.3. Devices
- 5.3.1. Condoms
- 5.3.2. Diaphragms
- 5.3.3. Contraceptive Sponges
- 5.3.4. Vaginal Rings
- 5.3.5. Cervical Cap
- 5.3.6. Subdermal Implants
- 5.3.7. Intra-uterine Devices

6. GLOBAL CONTRACEPTIVES MARKET, BY AGE GROUP

6.1. Overview
6.2. Age 15-24
6.3. Age 25-34
6.4. Age 35-44
6.5. Above 44

7. GLOBAL CONTRACEPTIVES MARKET, BY GENDER

7.1. Overview
7.2. Male
7.3. Female

8. GLOBAL CONTRACEPTIVES MARKET, BY GEOGRAPHY

8.1. Overview
8.2. North America
- 8.2.1. U.S.
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. Europe
- 8.3.1. Germany
- 8.3.2. U.K.
- 8.3.3. France
- 8.3.4. Rest of Europe
8.4. Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9. GLOBAL CONTRACEPTIVES MARKET COMPETITIVE LANDSCAPE

9.1. Overview
9.2. Company Market Ranking
9.3. Key Development Strategies

10. COMPANY PROFILES

10.1. Pfizer
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2. Bayer AG
- 10.2.1. Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Outlook
- 10.2.4. Key Developments
10.3. Johnson & Johnson
- 10.3.1. Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Outlook
- 10.3.4. Key Developments
10.4. Teva Pharmaceutical Industries Ltd.
- 10.4.1. Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Outlook
- 10.4.4. Key Developments
10.5. Novartis AG
- 10.5.1. Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Outlook
- 10.5.4. Key Developments
10.6. Merck & Co. Inc.
- 10.6.1. Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Outlook
- 10.6.4. Key Developments
10.7. Shionogi & Co. Ltd
- 10.7.1. Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Outlook
- 10.7.4. Key Developments
10.8. Hisamitsu Pharmaceutical Co. Inc.
- 10.8.1. Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Outlook
- 10.8.4. Key Developments
10.9. HIKMA Pharmaceuticals PLC
- 10.9.1. Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Outlook
- 10.9.4. Key Developments
10.10. Lupin Limited
- 10.10.1. Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Outlook
- 10.10.4. Key Developments